165 related articles for article (PubMed ID: 18066692)
1. Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary.
Kato N; Tamura G; Motoyama T
Virchows Arch; 2008 Feb; 452(2):175-80. PubMed ID: 18066692
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.
Kato N; Motoyama T
Histopathology; 2008 May; 52(6):682-8. PubMed ID: 18393978
[TBL] [Abstract][Full Text] [Related]
3. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
[TBL] [Abstract][Full Text] [Related]
4. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
Xiao W; Awadallah A; Xin W
Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.
Kato N; Toukairin M; Asanuma I; Motoyama T
Diagn Cytopathol; 2007 Apr; 35(4):193-7. PubMed ID: 17351940
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
Tsuchiya A; Sakamoto M; Yasuda J; Chuma M; Ohta T; Ohki M; Yasugi T; Taketani Y; Hirohashi S
Am J Pathol; 2003 Dec; 163(6):2503-12. PubMed ID: 14633622
[TBL] [Abstract][Full Text] [Related]
8. HNF-1β in ovarian carcinomas with serous and clear cell change.
DeLair D; Han G; Irving JA; Leung S; Ewanowich CA; Longacre TA; Gilks CB; Soslow RA
Int J Gynecol Pathol; 2013 Nov; 32(6):541-6. PubMed ID: 24071869
[TBL] [Abstract][Full Text] [Related]
9. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression.
Suzuki E; Kajita S; Takahashi H; Matsumoto T; Tsuruta T; Saegusa M
Lab Invest; 2015 Aug; 95(8):962-72. PubMed ID: 26030369
[TBL] [Abstract][Full Text] [Related]
11. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL
Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
[TBL] [Abstract][Full Text] [Related]
12. Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review).
Kajihara H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sado T; Oi H; Kobayashi H
Oncol Rep; 2010 May; 23(5):1193-203. PubMed ID: 20372830
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell death and induction of G2 arrest accumulation in human ovarian clear cells by HNF-1β transcription factor: chemosensitivity is regulated by checkpoint kinase CHK1.
Shigetomi H; Sudo T; Shimada K; Uekuri C; Tsuji Y; Kanayama S; Naruse K; Yamada Y; Konishi N; Kobayashi H
Int J Gynecol Cancer; 2014 Jun; 24(5):838-43. PubMed ID: 24804869
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma.
Okamoto T; Mandai M; Matsumura N; Yamaguchi K; Kondoh H; Amano Y; Baba T; Hamanishi J; Abiko K; Kosaka K; Murphy SK; Mori S; Konishi I
Mol Carcinog; 2015 Jan; 54(1):35-49. PubMed ID: 24105991
[TBL] [Abstract][Full Text] [Related]
15. Pathology of clear cell carcinoma of the ovary: A basic view based on cultured cells and modern view from comprehensive approaches.
Kato N
Pathol Int; 2020 Sep; 70(9):591-601. PubMed ID: 32476214
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.
Kato N; Sasou S; Motoyama T
Mod Pathol; 2006 Jan; 19(1):83-9. PubMed ID: 16258507
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases.
Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K
Medicine (Baltimore); 2016 Mar; 95(9):e3003. PubMed ID: 26945423
[TBL] [Abstract][Full Text] [Related]
19. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
20. The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary.
Kobayashi H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
Int J Gynecol Cancer; 2009 Apr; 19(3):471-9. PubMed ID: 19407577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]